Rheumatoid Arthritis Diagnostic Identra Panel 2
This rheumatoid arthritis diagnostic blood test panel bundles autoantibodies, inflammation markers, and immune proteins to clarify RA likelihood and related patterns.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a multi-marker lab panel designed to look at rheumatoid arthritis (RA) risk and closely related immune patterns in one blood draw. Instead of relying on a single result, it combines autoantibodies, inflammation markers, and immune protein measurements so your clinician can interpret the full pattern alongside your symptoms, exam, and imaging when needed.
Do I need this panel?
You may consider the Rheumatoid Arthritis Diagnostic Identra Panel 2 if you have symptoms that raise the question of inflammatory arthritis—especially persistent joint pain and morning stiffness, swelling in the small joints of the hands or feet, or symptoms that come and go but keep returning.
This panel can also be useful when your story is less classic: unexplained fatigue, “achy” joints with normal basic labs, or a prior positive autoimmune screen (like an ANA) that left you with more questions than answers. Because it includes multiple immune markers, it can help reduce false reassurance from a single “normal” test and reduce catastrophizing from a single “positive” test by putting results in context.
If you have recurrent sinus or lung infections, frequent antibiotic courses, or a history that makes your clinician wonder about immune function, the immunoglobulin portion of the panel can add helpful information alongside the RA-focused markers.
This panel supports clinician-directed care and shared decision-making; it is not meant to diagnose you on its own or replace an evaluation by a qualified clinician.
Results and reference ranges can vary by lab method; your clinician should interpret this panel using the reference intervals shown on your report and your clinical context.
Lab testing
Order the Rheumatoid Arthritis Diagnostic Identra Panel 2
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a rheumatoid arthritis-focused lab panel when you and your clinician want a broader immune picture than a single test can provide. You can complete the blood draw through a major lab network and view your results in one place.
Because this is a panel, the value is in the pattern: how autoantibodies, inflammation markers, and immune proteins line up (or don’t) with your symptoms. If your results raise questions—like a borderline antibody, a mismatch between inflammation markers and symptoms, or immunoglobulin subclass findings—PocketMD can help you organize follow-up questions and next steps for your clinician.
If you are tracking changes over time (for example, before and after treatment changes, postpartum, or after a flare), repeating the same panel can make trends easier to interpret than mixing different test sets from different dates.
- One order, multiple immune and inflammation markers in a single draw
- Designed for pattern-based interpretation rather than single-result guessing
- Clear next-step prompts you can take to your clinician
- Optional PocketMD support for understanding multi-marker results
Key benefits of Rheumatoid Arthritis Diagnostic Identra Panel 2
- Checks multiple RA-associated autoantibodies together, which can improve clinical clarity compared with ordering one marker alone.
- Pairs antibody results with inflammation markers to help distinguish “immune activity” from non-inflammatory pain patterns.
- Helps contextualize a positive ANA by looking for more RA-specific signals and related immune findings.
- Supports earlier, more targeted follow-up (imaging, rheumatology referral, or repeat testing) when the pattern suggests inflammatory arthritis.
- Provides immune protein measurements (immunoglobulins and subclasses) that can be relevant when infections or immune deficiency are part of the story.
- Creates a baseline you can trend over time to monitor flares, treatment response, or evolving symptoms.
- Reduces over-interpretation of a single abnormal value by emphasizing the full panel pattern and pretest probability.
What is the Rheumatoid Arthritis Diagnostic Identra Panel 2 panel?
The Rheumatoid Arthritis Diagnostic Identra Panel 2 is a bundled blood test panel that looks at several categories of markers commonly used in autoimmune and inflammatory workups. It is designed to support evaluation for rheumatoid arthritis (RA) and to surface related immune patterns that can affect how results are interpreted.
Most RA evaluations rely on three pillars: (1) your symptoms and physical exam (for example, swollen tender joints and prolonged morning stiffness), (2) imaging when appropriate (ultrasound or X-ray), and (3) labs that look for immune system signals. This panel focuses on the lab pillar by combining:
• Autoantibodies associated with RA and connective tissue disease (for example rheumatoid factor and anti-CCP, plus screening antibodies like ANA). • Inflammation markers that reflect systemic inflammatory activity (for example CRP and ESR). • Immune protein measurements (immunoglobulins and, in some panels, IgG subclasses) that can help interpret immune activation, immune deficiency, or chronic immune stimulation.
No single blood test “proves” RA. Some people with RA have negative antibodies (seronegative RA), and some people without RA can have positive antibodies. The goal of a panel is to improve signal-to-noise: when multiple results point in the same direction, your clinician can be more confident about next steps; when results conflict, it highlights where careful clinical correlation matters most.
How this panel fits into an RA workup
If your symptoms suggest inflammatory arthritis, RA-specific antibodies (especially anti-CCP) can increase the likelihood that RA is the right diagnosis. Inflammation markers can support the presence of active inflammation, but they are not specific to RA. Immune protein results can help explain why you might be getting infections, why inflammation markers behave unexpectedly, or why antibody tests may be harder to interpret in certain immune states.
Why a panel can be more useful than a single test
Ordering only one marker can lead to dead ends: a normal CRP does not rule out inflammatory arthritis, and a positive ANA does not diagnose RA. A bundled panel helps you and your clinician see whether results cluster into a coherent pattern (RA-leaning, non-specific inflammation, immune deficiency signals, or a largely reassuring profile).
What do my panel results mean?
When key parts of the panel are low or negative
A “low/negative” pattern usually means RA-associated autoantibodies are not detected (or are below the lab’s cutoff) and inflammation markers are not elevated. This can be reassuring, but it does not automatically rule out inflammatory arthritis—especially if you have clear joint swelling, prolonged morning stiffness, or symptoms that strongly fit an inflammatory pattern. In some people, antibodies appear later, and some RA is seronegative. If immunoglobulins are low, the interpretation changes: low immune proteins can be associated with immune deficiency and may affect how your body produces antibodies, which is a reason to review the full panel together rather than focusing on one line.
When the panel is broadly in-range and consistent
An “in-range” pattern typically means inflammation markers are within the lab’s reference interval and immune proteins are not showing a clear deficiency or excess, while RA-specific antibodies are negative. In this situation, your clinician may focus on other explanations for symptoms (mechanical joint issues, osteoarthritis, thyroid disease, viral illness recovery, sleep and stress factors, or other autoimmune conditions depending on your history). If symptoms persist, the most useful next step is often not repeating a single marker, but matching retesting to clinical changes (for example, during a flare) and considering imaging or a rheumatology exam.
When several markers are elevated or cluster together
A “high” pattern can look different depending on which category is elevated. RA likelihood increases most when RA-associated autoantibodies (especially anti-CCP and/or rheumatoid factor) are clearly positive and your symptoms fit inflammatory arthritis. Elevated CRP and/or ESR can support active inflammation, but they can also rise with infection, injury, obesity, and many inflammatory conditions. If immunoglobulins (or IgG subclasses) are elevated, it may reflect chronic immune stimulation or inflammation; if they are low, it may point toward immune deficiency, which can coexist with autoimmune features in some people. The most actionable interpretation comes from the combination: antibody positivity plus inflammatory symptoms is more meaningful than any single elevated value.
Factors that influence this panel
Several real-world factors can shift results without changing the underlying diagnosis. Recent infections, vaccines, surgery, or intense training can temporarily raise CRP/ESR. Anti-inflammatory medications (including steroids and some biologics) can lower inflammation markers and sometimes reduce antibody titers over time. Smoking history is associated with higher risk of anti-CCP positivity and RA in susceptible people. Pregnancy and postpartum immune shifts can change symptoms and inflammatory markers. If you have low immunoglobulins or are on immune-modifying therapy, antibody tests may be harder to interpret because your immune system may not produce typical antibody levels. Always read the panel using the reference ranges on your report and your current clinical picture.
What’s included in this panel
- Cyclic Citrullinated Peptide (Ccp) Ab (Igg)
- Mutated Citrullinated Vimentin (Mcv) Ab
- Rheumatoid Factor
Frequently Asked Questions
Can this panel diagnose rheumatoid arthritis by itself?
No. RA is diagnosed using your symptoms, physical exam, and sometimes imaging, with labs used to support (or make less likely) certain diagnoses. This panel can strengthen or weaken the case for RA depending on the overall pattern—especially anti-CCP/RF results—but it is not a standalone diagnosis.
What’s the difference between rheumatoid factor (RF) and anti-CCP?
RF is an antibody that can be present in RA but can also be positive in other autoimmune conditions, chronic infections, and sometimes with aging. Anti-CCP (often reported as anti-CCP IgG) is generally more specific for RA, and a clear positive result can be more informative when your symptoms fit inflammatory arthritis.
If my ANA is positive, does that mean I have RA?
Not necessarily. ANA is a screening antibody that can be positive in many autoimmune conditions and can also be positive in healthy people. In an RA workup, a positive ANA is interpreted alongside RA-specific antibodies (like anti-CCP), inflammation markers, and your clinical picture.
Do I need to fast for this blood test panel?
Fasting is usually not required for antibody tests, CRP/ESR, or immunoglobulins. However, some panels include metabolic markers (for example a CMP) where your clinician may prefer consistent timing and hydration. Follow the instructions provided with your order and keep your routine consistent if you are trending results over time.
How should I interpret mixed results, like high CRP but negative RF and anti-CCP?
That pattern can happen. CRP/ESR are non-specific inflammation markers and can rise with infection, injury, obesity, and many inflammatory conditions. Negative RA antibodies can make RA less likely, but they do not fully rule it out. Mixed results are a reason to review symptoms, exam findings, and possibly imaging rather than relying on a single lab line.
Why are immunoglobulins and IgG subclasses included in an RA-focused panel?
Immune protein levels can add context, especially if you have recurrent infections, unusual responses to vaccines, or immune-modifying medications. Low immunoglobulins can point toward immune deficiency and can affect how antibody tests behave; high levels can reflect chronic immune stimulation. They are not RA-specific, but they can change how the overall immune picture is interpreted.
Is it better to order a panel or just RF and anti-CCP?
If the question is narrowly “does this look like RA?” RF and anti-CCP may be a starting point. A panel can be more useful when symptoms are non-specific, when prior tests were confusing (like a positive ANA), when you want inflammation markers interpreted alongside antibodies, or when immune function questions (like recurrent infections) are part of the story.